A1
L-citrulline
- Product declaration
- L-Citrulline: 6 g
- Selected studied range
- 3000 to 9000 mg
- Protocol and duration
- per day, in the studies NIH ODS summarizes
- Studied context
- Studied as a nitric-oxide pathway precursor (converted to arginine via the urea cycle) for aerobic exercise performance measures such as oxygen-uptake (VO2) kinetics, blood lactate, and rate of perceived exertion, and for acute resistance-exercise performance and muscle oxygenation. NIH ODS describes evidence for enhancing performance as limited, with few studies and conflicting results.
- Limitations
- A 2022 systematic review/meta-analysis found no significant benefit for endurance-performance outcomes specifically. A single 8 g acute dose did not enhance isometric force production, muscle endurance, or muscle-oxygenation parameters in one resistance-exercise study. NIH ODS characterizes overall performance-enhancement evidence as limited.
Selected evidence: NIH ODS, Dietary Supplements for Exercise and Athletic Performance · Open source
A2
Beta-alanine
- Product declaration
- Beta Alanine: 5 g
- Selected studied range
- 4000 to 6000 mg
- Protocol and duration
- per day in divided doses, for at least 2 to 4 weeks, not as a single pre-workout dose
- Studied context
- Studied for high-intensity exercise capacity in the 60-240 second range via elevation of muscle carnosine, which acts as an intracellular pH buffer against acidosis. ISSN 2015 position stand: greatest performance benefits in "open end-point" tasks/time trials lasting 1-4 minutes; some benefit noted in aerobic exercise up to roughly 25 minutes; attenuation of neuromuscular fatigue, particularly noted in older adults.
- Limitations
- Strength/resistance-training outcomes remain mixed; training volume may increase without a clear strength gain. Tasks under 60 seconds do not show benefit. Endurance benefit beyond about 25 minutes is not established. Long-term safety data beyond roughly a year, and effects in special/tactical populations, are flagged as needing more research.
Selected evidence: ISSN position stand on beta-alanine, 2015 · Open source
A2
Caffeine
- Product declaration
- Total caffeine from all declared sources: 200 mg
- Selected studied range
- 140 to 420 mg
- Protocol and duration
- 2 to 6 mg per kg body mass, 15 to 60 minutes before exercise, shown here for a 70 kg adult
- Studied context
- Studied for endurance-type aerobic exercise (moderate to large ergogenic effect, most consistent evidence category per ISSN 2021), muscular endurance and movement velocity in resistance exercise (small to moderate effects), sprinting/jumping/throwing (2-7% improvements), and cognitive attention/vigilance under fatigue. NIH ODS notes it "might enhance performance in endurance-type activities... And intermittent, long-duration activities."
- Limitations
- Minimal effective dose remains unclear. Repeated-sprint performance benefit is inconsistent and the ISSN position stand says this "requires further research." Effects of habitual/chronic caffeine use on the ergogenic response are described as equivocal.
Selected evidence: ISSN position stand on caffeine and exercise performance, 2021, with NIH ODS · Open source